Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’

Saved in:
Bibliographic Details
Published inESMO open Vol. 7; no. 6; p. 100599
Main Authors Takada, K., Takamori, S.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2022
Elsevier
Subjects
Biomarkers
Carcinoma, Non-Small-Cell Lung - drug therapy
Correspondence
Humans
Immune Checkpoint Inhibitors - pharmacology
Immune Checkpoint Inhibitors - therapeutic use
Inflammation - drug therapy
Lung Neoplasms - drug therapy
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2022.100599